234 related articles for article (PubMed ID: 35800370)
1. Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response.
Zhao T; Wang X; Fu L; Yang K
Cancer Drug Resist; 2022; 5(2):436-450. PubMed ID: 35800370
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
[TBL] [Abstract][Full Text] [Related]
3.
Yang Z; Ji G
Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
[TBL] [Abstract][Full Text] [Related]
4.
Wang S; Liu Y; Li J; Zhao L; Yan W; Lin B; Guo X; Wei Y
Front Cell Dev Biol; 2021; 9():710165. PubMed ID: 34490259
[TBL] [Abstract][Full Text] [Related]
5.
Kong C; Yan X; Zhu Y; Zhu H; Luo Y; Liu P; Ferrandon S; Kalady MF; Gao R; He J; Yin F; Qu X; Zheng J; Gao Y; Wei Q; Ma Y; Liu JY; Qin H
Cancer Res; 2021 Sep; 81(17):4485-4498. PubMed ID: 34162680
[TBL] [Abstract][Full Text] [Related]
6. The onco-immunological implications of Fusobacterium nucleatum in breast cancer.
Van der Merwe M; Van Niekerk G; Botha A; Engelbrecht AM
Immunol Lett; 2021 Apr; 232():60-66. PubMed ID: 33647328
[TBL] [Abstract][Full Text] [Related]
7. A New Comorbidity in Periodontitis:
Mesa F; Mesa-López MJ; Egea-Valenzuela J; Benavides-Reyes C; Nibali L; Ide M; Mainas G; Rizzo M; Magan-Fernandez A
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454384
[TBL] [Abstract][Full Text] [Related]
8. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
10. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer.
Liu Y; Baba Y; Ishimoto T; Iwatsuki M; Hiyoshi Y; Miyamoto Y; Yoshida N; Wu R; Baba H
J Gastroenterol; 2019 Jan; 54(1):33-41. PubMed ID: 30244399
[TBL] [Abstract][Full Text] [Related]
11.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
12. Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer.
Ramos A; Hemann MT
Cell; 2017 Jul; 170(3):411-413. PubMed ID: 28753421
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
[TBL] [Abstract][Full Text] [Related]
14. Association between
Zhang S; Cai S; Ma Y
J Cancer; 2018; 9(9):1652-1659. PubMed ID: 29760804
[TBL] [Abstract][Full Text] [Related]
15. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review.
Ranjbar M; Salehi R; Haghjooy Javanmard S; Rafiee L; Faraji H; Jafarpor S; Ferns GA; Ghayour-Mobarhan M; Manian M; Nedaeinia R
Cancer Cell Int; 2021 Apr; 21(1):194. PubMed ID: 33823861
[TBL] [Abstract][Full Text] [Related]
16. Microbiota Profile and Impact of
de Carvalho AC; de Mattos Pereira L; Datorre JG; Dos Santos W; Berardinelli GN; Matsushita MM; Oliveira MA; Durães RO; Guimarães DP; Reis RM
Front Oncol; 2019; 9():813. PubMed ID: 31555583
[TBL] [Abstract][Full Text] [Related]
17.
Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
[TBL] [Abstract][Full Text] [Related]
18. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Targeting Nanoassembly for Enhanced Colorectal Cancer Therapy by Eliminating Intratumoral
Li X; Ma Y; Xin Y; Ma F; Gao H
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916659
[No Abstract] [Full Text] [Related]
20. Carcinogenesis mechanisms of Fusobacterium nucleatum.
Gholizadeh P; Eslami H; Kafil HS
Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
